 |
|
|
|
|
We are a leader in developing a hemoglobin-based oxygen-carrying
red blood cell substitute. The initial indication we are seeking
for our product PolyHeme® is the treatment of life-threatening
hemoglobin levels when blood transfusion is indicated but red
blood cells may not be available, appropriate or acceptable. PolyHeme®
is a solution of chemically modified human hemoglobin that requires
no cross-matching and is therefore compatible with all blood types.
It has an extended shelf life in excess of 12 months. |
|
||
